WHEN blood CEA levels are used for monitoring response of malignant disease to chemotherapeutic agents, the correlation is often imprecise. Although over a long term, serial estimations will reflect disease progress (e.g. Steward et al., 1974; Borthwick et al., 1977; Mayer et al., 1978; Waalkes et al., 1980) paradoxical or discordant changes in CEA occur in up to 3000 of patients during the early and intermediate periods (Ravry & Moertel, 1974; Shani et al., 1978) . Furthermore, wide diurnal variations (up to 3-fold) may occur during chemotherapy (Skarin et al., 1974; Young et al., 1976) and even cases with low pretreatment blood CEA levels have been reported to develop grossly elevated levels in the early phase of remission (Waalkes et al., 1980) . A similar response often occurs after radiotherapy when, in addition, levels commonly remain elevated for periods of up to 6 weeks before gradually falling (Khoo & Mackay, 1976; Donaldson et al., 1976; Sugarbaker et al., 1978) . Of particular interest is that these elevations are most common during the mid-course of treatment, which is uisually the time when tumour breakdown is greatest. Whilst there may be many other factors involved, the possibility should therefore be considered that these changes may be due to tumour necrosis. In an investigation to determine whether this may be the case, an animal model system consisting of immune-deprived mice bearing human CEA-producing tumours has been used.
MATERIALS AND METHODS
Human tumours already established in transplant passage to immune-deprived mice. which had been found on screening to produce high titres of CEA in the blood of host mice, were used. These consisted of 4 colorectal (HK1, 6, 7, 9) , one breast (S32) and one lung (p246) tumours. Their characteristics, and the techniques of immune-deprivation, grafting and tumour measurement, together with methods for measuring circulation CEA levels have previously been described in the preceding article (Quayle, 1982 The results are illustrated in Fig. 1 . In 10/15 cryo groups there was an abrupt fall in CEA, but in the 5 in which this failed to occur there was a sharp elevation, usually >3 x the pretreatment titre, during the first 24 h. No significant change occurred in the control group. The reason for the abrupt fall in CEA in most of the cases is probably because cryosurgery had removed the blood supply within the tumour arising from its over-energetic use. Indeed there was definite macroscopic evidence of excessive coagulative 
Indirect procedures
Cytotoxic drugs. Previous screening of p246 lung (Mitchley et al., 1977) and HK6 colon (Nowak et al., 1978) had revealed response to the cytotoxic agent hexamethylmelamine (HMM). S32 breast response had not previously been assessed, but cyclophosphamide (CTX) was selected because of its reputation as one of the most effective agents in the treatment of breast-cancer patients (Carter, 1976 Irradiation. Mice bearing bilateral implants of S32 breast and p246 lung tumours were used. They were individually anaesthetized by i.p. infusions of pentobarbitone combined with penthrane inhalation, and then encased in a lead cylinder which had a small lateral aperture. Each implant in turn was positioned without tension on the outer aspect of the cylinder through the aperture. held by a small clip lightly applied to overlying skin and then exposed to 100 Gy irradiation delivered by an overhead 250 kV X-ray machine. Control mice were anaesthetized only.
Diphtheria toxin.-This agent was used because of its strong cytotoxic effect on human tumours maintained in immunedeficient mice, and its mild side effects in the hosts compared to humans (Kaplan et al., unpub.) Table I . It will be seen that in almost all cases untreated controls continued to grow. Dramatic responses followed diphtheria toxin, particularly in the colonic tumour groups, in which there was usually a size reduction > 50%0 by the 2nd week after treatment. S32 breast tumours also responded but to a lesser extent. The lung tumour p246, however, showed no evidence of regression.
In the HK9 colon group the response was complete and the residual tiny nodules were found on histology to consist of There were several examples in which paradoxical responses of CEA in relation to tumour response occurred. In particular, the most responsive tumour group to diphtheria toxin was the HK9 colon group, which was associated with the least uniform or extensive in terms of peak CEA elevations, but CEA eventually completely disappeared from the blood. This was demonstrated to a lesser degree following radiation to the S32 group, and following cytotoxic drugs in HKG as well as S32
groups.
There were temporal differences accord- (16) ( (10) 50 (6) 60 (5) In )aIeIitheses, number' mice.
Breast 832 85 (7) 66 (6) 25 ( ing to the treatment used. Following diphtheria toxin, rises in CEA became apparent usually in the first 12-24 h, and seldom within the first 6 h, or after 48 h. In most cases CEA would then remain at these high peaks for 24-48 h, but occasionally would persist for up to 5 days. The subsequent fall in CEA was rapid, usually returning to pretreatment levels in 24 h and thereafter gradually to zero over a further [2] [3] [4] Drewinko & Yang (1980) . By implication, CEA release would appear to be maximal when the "health" of the cell was compromised. The human in vivo responses supporting this hypothesis which were described in the introduction should, however, be regarded with some circumspection, because there may be many other processes operating.
The demonstration in this study of numerous instances when effective tumour lysis resulted in peak elevations of circulating CEA, does suggest that tumour necrosis and/or factors associated with this process may play a part in the release of CEA. HBowever, in extrapolating fronm data of these xenograft studies, it is essential to appreciate that the same may not apply in patients. The conditions were grossly artificial and the methods for inducing tumour necrosis were extreme.
As yet no such treatment as effective as diphtheria toxin on the xenograft model is available to clinical practice. It was surprising, however, that in the HK9 colon tumours, which were by far the best responders to diphtheria toxin, the changes in blood CEA were the least remarkable among the whole colon (HK) tumour group.
The concentration of CEA in the circulation is likely to be maintained in a state of dynamic equilibrium by a set of complex factors affecting the source of CEA in the tissues, the processes by which it is released from tumour tissue into the blood, and its subsequent metabolism. Whilst tumour lysis may be a factor responsible for elevated blood CEA levels, it would seem unlikely to make a 218 E . major contribution to the many other factors, unless the process were extensive and rapid. The possibility should continue to be entertained, however, that tumour lysis may in part be responsible for the discordant changes which take place in patients during chemo-and radiotherapy.
